Cargando…

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer-Helmich, Lene, Haro, Josep Maria, Jönsson, Bengt, Tanguy Melac, Audrey, Di Nicola, Sylvie, Chollet, Julien, Milea, Dominique, Rive, Benoît, Saragoussi, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767094/
https://www.ncbi.nlm.nih.gov/pubmed/29386897
http://dx.doi.org/10.2147/NDT.S146098
_version_ 1783292478982455296
author Hammer-Helmich, Lene
Haro, Josep Maria
Jönsson, Bengt
Tanguy Melac, Audrey
Di Nicola, Sylvie
Chollet, Julien
Milea, Dominique
Rive, Benoît
Saragoussi, Delphine
author_facet Hammer-Helmich, Lene
Haro, Josep Maria
Jönsson, Bengt
Tanguy Melac, Audrey
Di Nicola, Sylvie
Chollet, Julien
Milea, Dominique
Rive, Benoît
Saragoussi, Delphine
author_sort Hammer-Helmich, Lene
collection PubMed
description BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment. METHODS: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined. RESULTS: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up. CONCLUSION: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice.
format Online
Article
Text
id pubmed-5767094
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57670942018-01-31 Functional impairment in patients with major depressive disorder: the 2-year PERFORM study Hammer-Helmich, Lene Haro, Josep Maria Jönsson, Bengt Tanguy Melac, Audrey Di Nicola, Sylvie Chollet, Julien Milea, Dominique Rive, Benoît Saragoussi, Delphine Neuropsychiatr Dis Treat Original Research BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment. METHODS: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined. RESULTS: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up. CONCLUSION: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice. Dove Medical Press 2018-01-09 /pmc/articles/PMC5767094/ /pubmed/29386897 http://dx.doi.org/10.2147/NDT.S146098 Text en © 2018 Hammer-Helmich et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Hammer-Helmich, Lene
Haro, Josep Maria
Jönsson, Bengt
Tanguy Melac, Audrey
Di Nicola, Sylvie
Chollet, Julien
Milea, Dominique
Rive, Benoît
Saragoussi, Delphine
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_full Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_fullStr Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_full_unstemmed Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_short Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_sort functional impairment in patients with major depressive disorder: the 2-year perform study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767094/
https://www.ncbi.nlm.nih.gov/pubmed/29386897
http://dx.doi.org/10.2147/NDT.S146098
work_keys_str_mv AT hammerhelmichlene functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT harojosepmaria functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT jonssonbengt functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT tanguymelacaudrey functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT dinicolasylvie functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT cholletjulien functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT mileadominique functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT rivebenoit functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT saragoussidelphine functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy